Breaking into the US healthcare market is one of the toughest challenges for medtech and healthtech founders and most underestimate just how slow, disciplined, and evidence-driven it really is. In this 5 in 5 from The H-Files episode, I share five hard-earned lessons from working with companies trying to scale into the US. In just five minutes, you’ll learn why speed doesn’t equal success, how the wrong distributor can quietly kill momentum, and why clinical data and cash flow matter more than optimism.

This episode covers:

1. Why the US healthcare market rewards preparation, not speed
2. How to spot weak or generalist distributors
3. Why clinical proof is non-negotiable in US sales
4. The real cash realities of US distribution
5. How to avoid partnerships that look good early but fail later

If you’re a medtech founder, healthtech leader, or healthcare startup planning US expansion, this episode will help you avoid costly mistakes and build a strategy that actually works. Comment or message which action you took and what surprised you.

Listen to Full Episode: https://youtu.be/3v8N7F2gGqo

Listen on Apple Podcasts: https://podcasts.apple.com/gb/podcast/hands-on-business-the-h-files-unlocking-growth/id1548129226

Join the mailing list to get the show notes for every episode here: https://thesalesaccelerationformula.com/podcast-show-notes

#healthcare #us #usmarket #5in5 #podcast #hfiles #medtech